SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001607062-19-000017
Filing Date
2019-01-11
Accepted
2019-01-11 16:38:01
Documents
6
Period of Report
2019-01-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K gnbt011119form8k.htm 8-K 43962
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 216269
3 EXHIBIT 10.2 ex10_2.htm EX-10.2 15724
4 EXHIBIT 10.3 ex10_3.htm EX-10.3 22752
5 EXHIBIT 10.4 ex10_4.htm EX-10.4 97445
6 EXHIBIT 10.5 ex10_5.htm EX-10.5 43668
  Complete submission text file 0001607062-19-000017.txt   440906
Mailing Address 10102 USA TODAY WAY MIRAMAR FL 33025
Business Address 10102 USA TODAY WAY MIRAMAR FL 33025 416-364-2551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 000-25169 | Film No.: 19522663
SIC: 2834 Pharmaceutical Preparations